|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.998
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.992
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.977
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.965
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.960
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.959
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.957
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.950
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.949
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.934
|
Zebrafish |
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.924
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.920
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.911
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.899
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.897
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.888
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.879
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.870
|
Zebrafish |
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.857
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.857
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.840
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.825
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.825
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.822
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.810
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.779
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.776
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.763
|
Zebrafish |
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.739
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.720
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.713
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.708
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.707
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.707
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.704
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.680
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.676
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.666
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.665
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.662
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.641
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.638
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.637
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.624
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.621
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.620
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.618
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.615
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.602
|
|
|
|
stress response to metal ion
|
GO:0097501 |
3 |
0.599
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.580
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.569
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.562
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.553
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.546
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.545
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.536
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.525
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.514
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.511
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.510
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.509
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.504
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.490
|
|
|
|
cell aggregation
|
GO:0098743 |
18 |
0.484
|
|
|
|
positive regulation of interferon gamma secretion
|
GO:1902715 |
3 |
0.478
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.473
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.472
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.452
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.451
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.450
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.447
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.443
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.442
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.438
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.437
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.434
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.430
|
|
|
|
negative regulation of vasoconstriction
|
GO:0045906 |
2 |
0.418
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.406
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.398
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.393
|
|
|
|
sequestering of bmp in extracellular matrix
|
GO:0035582 |
3 |
0.391
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.386
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.381
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.375
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.373
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.368
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.367
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.362
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.357
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.356
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.354
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.351
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.349
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.339
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.336
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.323
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.320
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.316
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.306
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.297
|
|
|
|
mononuclear cell migration
|
GO:0071674 |
8 |
0.292
|
|
|
|
regulation of gastrulation
|
GO:0010470 |
16 |
0.290
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.283
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.280
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.277
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.275
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.275
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.274
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.271
|
|
|
|
phospholipase c activating angiotensin activated signaling pathway
|
GO:0086097 |
1 |
0.269
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.266
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.263
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.263
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.258
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.257
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.255
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.253
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.252
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.244
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.243
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.241
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.239
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.234
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.233
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.232
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.229
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.225
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.216
|
|
|
|
regulation of lung blood pressure
|
GO:0014916 |
2 |
0.214
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.210
|
|
|
|
regulation of superoxide metabolic process
|
GO:0090322 |
8 |
0.207
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.207
|
|
|
|
regulation of macrophage chemotaxis
|
GO:0010758 |
8 |
0.206
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.206
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.204
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.203
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.202
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.202
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.200
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.200
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.199
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.196
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.195
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.195
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.194
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.193
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.192
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.185
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.185
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.185
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.185
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.181
|
|
|
|
response to interleukin 1
|
GO:0070555 |
11 |
0.180
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.179
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.178
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.175
|
|
|
|
regulation of cell adhesion mediated by integrin
|
GO:0033628 |
13 |
0.174
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.173
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.171
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.171
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.171
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.166
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.165
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.164
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.164
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.164
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.163
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.159
|
|
|
|
basement membrane organization
|
GO:0071711 |
8 |
0.157
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.156
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.155
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.155
|
|
|
|
ovarian cumulus expansion
|
GO:0001550 |
1 |
0.154
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.153
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.153
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.152
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.152
|
|
|
|
regulation of tolerance induction to self antigen
|
GO:0002649 |
1 |
0.151
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.150
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.149
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.149
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.148
|
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
2 |
0.148
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.148
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.147
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.145
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.145
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.145
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.141
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.141
|
|
|
|
positive regulation of macrophage chemotaxis
|
GO:0010759 |
5 |
0.139
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.139
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.139
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.135
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.134
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.132
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.131
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.130
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.130
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.130
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.127
|
|
|
|
positive regulation of metalloenzyme activity
|
GO:0048554 |
3 |
0.127
|
|
|
|
tryptophan metabolic process
|
GO:0006568 |
4 |
0.127
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.125
|
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.125
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902218 |
1 |
0.125
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.125
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.123
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.122
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.121
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.120
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.120
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.120
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.119
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.118
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.118
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.117
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.116
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.116
|
|
|
|
negative regulation of endothelial cell differentiation
|
GO:0045602 |
2 |
0.115
|
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.114
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.114
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.114
|
|
|
|
negative regulation of cell adhesion mediated by integrin
|
GO:0033629 |
2 |
0.114
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.114
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.114
|
|
|
|
indolalkylamine metabolic process
|
GO:0006586 |
4 |
0.114
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.113
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.113
|
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.112
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.111
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.111
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.111
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.111
|
|
|
|
activation of mapkk activity
|
GO:0000186 |
15 |
0.108
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.108
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.107
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.105
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.104
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.104
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.103
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.103
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.102
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.100
|
|
|
|
tyrosine metabolic process
|
GO:0006570 |
4 |
0.100
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.100
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.100
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.099
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.099
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.099
|
|
|
|
neural plate mediolateral regionalization
|
GO:0021998 |
1 |
0.098
|
|
|
|
positive regulation of bone resorption
|
GO:0045780 |
13 |
0.097
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.097
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.097
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.096
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.096
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.096
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.096
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.095
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.094
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.094
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.092
|
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.091
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.091
|
|
|
|
regulation of response to reactive oxygen species
|
GO:1901031 |
9 |
0.089
|
|
|
|
positive regulation of monooxygenase activity
|
GO:0032770 |
2 |
0.088
|
|
|
|
fused antrum stage
|
GO:0048165 |
1 |
0.087
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.086
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.086
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.085
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.084
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.084
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.083
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1990127 |
1 |
0.083
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.083
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.082
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.081
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.081
|
|
|
|
macrophage chemotaxis
|
GO:0048246 |
14 |
0.081
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.081
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.080
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.078
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.078
|
|
|
|
negative regulation of chemotaxis
|
GO:0050922 |
11 |
0.077
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.077
|
|
|
|
positive regulation of tolerance induction to self antigen
|
GO:0002651 |
1 |
0.077
|
|
|
|
positive regulation of macrophage activation
|
GO:0043032 |
10 |
0.076
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.076
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.076
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.075
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.074
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.074
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.074
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.074
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.074
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.073
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.073
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.073
|
|
|
|
negative regulation of fatty acid transport
|
GO:2000192 |
1 |
0.072
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.072
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.072
|
|
|
|
nitric oxide mediated signal transduction
|
GO:0007263 |
4 |
0.071
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.071
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.071
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.070
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.069
|
|
|
|
extracellular matrix dependent thymocyte migration
|
GO:0072680 |
1 |
0.069
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.069
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.069
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.068
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.068
|
|
|
|
receptor recycling
|
GO:0001881 |
11 |
0.068
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.068
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.068
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.067
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.066
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.066
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.066
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.066
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.066
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.065
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.064
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.064
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.064
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.064
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.064
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.063
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.063
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.063
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.062
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.062
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.062
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.061
|
|
|
|
positive regulation of tissue remodeling
|
GO:0034105 |
19 |
0.061
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.061
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.060
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.060
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.060
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.059
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.059
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.059
|
|
|
|
superoxide anion generation
|
GO:0042554 |
11 |
0.059
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.059
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.059
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.059
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.059
|
|
|
|
response to dexamethasone
|
GO:0071548 |
8 |
0.058
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.058
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.058
|
|
|
|
negative regulation of epithelial cell migration
|
GO:0010633 |
9 |
0.057
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.057
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.057
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.057
|
|
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.057
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.057
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.056
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.056
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.056
|
|
|
|
sequestering of extracellular ligand from receptor
|
GO:0035581 |
6 |
0.055
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.055
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.055
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.055
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.054
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.054
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.054
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.054
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.054
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.054
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.053
|
|
|
|
negative regulation of anti mullerian hormone signaling pathway
|
GO:1902613 |
1 |
0.053
|
|
|
|
peptide cross linking
|
GO:0018149 |
10 |
0.052
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.052
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.052
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.052
|
|
|
|
regulation of superoxide anion generation
|
GO:0032928 |
4 |
0.052
|
|
|
|
negative regulation of insulin secretion
|
GO:0046676 |
14 |
0.051
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.051
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.051
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.051
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.050
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.050
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.050
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.050
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.049
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.049
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.049
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.049
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.049
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.049
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.048
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.047
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.047
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.047
|
|
|
|
cellular response to corticosteroid stimulus
|
GO:0071384 |
13 |
0.047
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.046
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.046
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.046
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.046
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.046
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.045
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
11 |
0.045
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.045
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.045
|
|
|
|
negative regulation of endothelial cell proliferation
|
GO:0001937 |
8 |
0.045
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.045
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.044
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.044
|
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.044
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.044
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.044
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.044
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.043
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.043
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.043
|
|
|
|
response to copper ion
|
GO:0046688 |
3 |
0.043
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.042
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.042
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.042
|
|
|
|
cgmp mediated signaling
|
GO:0019934 |
3 |
0.042
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.042
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.042
|
|
|
|
mesoderm structural organization
|
GO:0048338 |
1 |
0.042
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.042
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.041
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.041
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.041
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.041
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.041
|
|
|
|
contact inhibition
|
GO:0060242 |
3 |
0.041
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.041
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.041
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.041
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.041
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.040
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.040
|
|
|
|
regulation of membrane protein ectodomain proteolysis
|
GO:0051043 |
3 |
0.040
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
22 |
0.040
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.040
|
|
|
|
positive regulation of b cell tolerance induction
|
GO:0002663 |
2 |
0.040
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.040
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.040
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.039
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.039
|
|
|
|
positive regulation of adiponectin secretion
|
GO:0070165 |
1 |
0.039
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.039
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.039
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.039
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.039
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.039
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.039
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.039
|
|
|
|
positive regulation of cell migration involved in sprouting angiogenesis
|
GO:0090050 |
3 |
0.039
|
|
|
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.039
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.039
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.038
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.038
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.038
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.038
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.038
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.038
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.038
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.038
|
|
|
|
anatomical structure arrangement
|
GO:0048532 |
20 |
0.038
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.038
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.038
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.038
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.037
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.037
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.037
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.037
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
17 |
0.037
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.037
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.037
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.036
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.036
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.036
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.036
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
13 |
0.036
|
|